Regeneron Pharmaceuticals, Inc.;University Health Network (UHN)
发明人:
PURCELL NGAMBO, LISA ARLEEN,HIGGINS, SARAH J.,KAIN, KEVIN C.
申请号：
PL14800207
公开号：
PL3062811T3
申请日:
2014.10.31
申请国别(地区):
PL
年份:
2019
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
